Please assess the completion status of the following clinical trial:

Trial Title: Brief Behavioral Intervention for Dyspnea in Patients With Advanced Lung Cancer

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: SUPPORTIVE_CARE
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* A diagnosis of either NSCLC, SCLC, or mesothelioma, not being treated with curative intent~* Self-reported shortness of breath (a score of 2 or greater on the Modified Medical Research Council Dyspnea Scale)~* Eastern Cooperative Oncology Group (ECOG) Performance Status from 0 (asymptomatic) to 2 (symptomatic and in bed \<50% of day)~* The ability to read and respond to questions English~* Primary cancer care at the Massachusetts General Hospital (MGH) Cancer Center or Dana-Farber Cancer Institute (DFCI)~* Age \>18 years~Exclusion Criteria:~* Cognitive or psychiatric conditions prohibiting study consent or participation.~* A treating clinician who reports that the patient is inappropriate for the study

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Usual Care (Type: ACTIVE_COMPARATOR): Patients will receive any usual care for their dyspnea as deemed appropriate by their clinicians.
- Dyspnea Intervention (Type: EXPERIMENTAL): Dyspnea intervention will be administered over two sessions~Patients will receive:~* Psychoeducation~* Relaxation training for reducing physiological stress~* Behavioral techniques for managing acute breathlessness

Based on this trial design, predict the completion outcome and termination type (if applicable).